Tigecycline crystalline forms and processes for preparation...

Details Tigecycline crystalline forms and processes for preparation... Tigecycline crystalline forms and processes for preparation...

2011-01-18

2011-01-18

Kwon, Brian-Yong S (Department: 1613)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

3,10-dihydroxy-2-naphthacene carboxamide or derivative doai

C552S205000

Reexamination Certificate

active

07871993

ABSTRACT:
The present invention relates to solid crystalline Tigecycline, and crystalline forms thereof.

REFERENCES:
patent: 2980584 (1961-04-01), Hammer
patent: 2990331 (1961-06-01), Newmann et al.
patent: 2997471 (1961-08-01), Cheney et al.
patent: 3062717 (1962-11-01), Hammer
patent: 3165531 (1965-01-01), Blackwood et al.
patent: 3454697 (1969-07-01), Joyner et al.
patent: 3557280 (1971-01-01), Weber et al.
patent: 3674859 (1972-07-01), Beutel et al.
patent: 3957980 (1976-05-01), Noseworthy
patent: 4018889 (1977-04-01), Armstrong
patent: 4024272 (1977-05-01), Rogalski et al.
patent: 4126680 (1978-11-01), Armstrong
patent: 5240879 (1993-08-01), De Bruin et al.
patent: 5248797 (1993-09-01), Sum
patent: 5281628 (1994-01-01), Hlavka et al.
patent: 5284963 (1994-02-01), Sum et al.
patent: 5401863 (1995-03-01), Hlavka et al.
patent: 5494903 (1996-02-01), Hlavka et al.
patent: 5495031 (1996-02-01), Sum et al.
patent: 5675030 (1997-10-01), Krishnan et al.
patent: 2006/0183720 (2006-08-01), Sum et al.
patent: 2006/0247181 (2006-11-01), Fawzi
patent: 2007/0026080 (2007-02-01), Chanana
patent: 2007/0049560 (2007-03-01), Krishnan
patent: 2007/0049561 (2007-03-01), Krishnan
patent: 2007/0049562 (2007-03-01), Krishnan
patent: 2007/0049563 (2007-03-01), Krishnan
patent: 2007/0123497 (2007-05-01), Krishnan et al.
patent: 535346 (1993-04-01), None
patent: 876500 (1961-09-01), None
patent: 01-029346 (1989-01-01), None
patent: WO 02/072031 (2002-09-01), None
patent: 2006/128150 (2006-11-01), None
patent: 2006128150 (2006-11-01), None
patent: 2006130501 (2006-12-01), None
patent: WO 2006/130431 (2006-12-01), None
patent: WO 2008/066935 (2008-06-01), None
patent: WO 2008/155405 (2008-12-01), None
J. Am. Chem. Soc., 1953, 75, 4621.
J. Am. Chem. Soc., 1960, 82, 1253.
J. Med. Chem., 1962, 5(3), 538.
J. Med. Chem., 1994, 37, 184.
International Search Report recieved for corresponding PCT Application No. PCT/US2007/010108.
Measuring colour, 3rd Ed. / R.W.G. Hunt (1998).
Polymorphism in Pharmaceutical Solids, Drugs and the Pharmaceutical Sciences, vol. 95, Publication year: 1999. S.E.C.
Anonymous, “Tygacil Scientific Discussion”, EMEA 2006 http://www.infectiologie.com/site/medias/enseignment/du-lyon/Trygacil%20EPAR.pdf.
Database WPI Week 198910. Derwent Publicatons Ltd., London, GB: An 1989-074689, JP01029346A (Nippon Kayaku KK) Jan. 31, 1989 (Abstract).
J.Med.Chem 37: 184 (1994).
Nelson et al., “Versatile and Facile Synthesis of Diverse Semisynthetic Tetracycline Derivatives via Pd-Catalyzed Reactions”, Journal of Organic Chemistry, 68: 5838-5851 (2003).
Sum et al., “Synthesis and Structure—Activity Relationship of Novel Glycylcycline Derivatives Leading to the Discovery of GAR-936,”Bioorganic&Medicinal Chemistry Letters, 9: 1459-1462 (1999).
March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure; 5thEd., Publication year: 2001. S.E.C.

Affiliated with

Also associated with

Rating

Tigecycline crystalline forms and processes for preparation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tigecycline crystalline forms and processes for preparation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tigecycline crystalline forms and processes for preparation... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2680657